Scinovex
reviewTop 1% cited

Myeloperoxidase: a front-line defender against phagocytosed microorganisms

Journal of Leukocyte Biology · 2012 · Vol. 93(2) · pp. 185–198
Seymour J. KlebanoffAnthony J. KettleHenry RosenChristine C. WinterbournWilliam M. Nauseef

Abstract

Successful immune defense requires integration of multiple effector systems to match the diverse virulence properties that members of the microbial world might express as they initiate and promote infection. Human neutrophils--the first cellular responders to invading microbes--exert most of their antimicrobial activity in phagosomes, specialized membrane-bound intracellular compartments formed by ingestion of microorganisms. The toxins generated de novo by the phagocyte NADPH oxidase and delivered by fusion of neutrophil granules with nascent phagosomes create conditions that kill and degrade ingested microbes. Antimicrobial activity reflects multiple and complex synergies among the phagosomal contents, and optimal action relies on oxidants generated in the presence of MPO. The absence of life-threatening infectious complications in individuals with MPO deficiency is frequently offered as evidence that the MPO oxidant system is ancillary rather than essential for neutrophil-mediated antimicrobial activity. However, that argument fails to consider observations from humans and KO mice that demonstrate that microbial killing by MPO-deficient cells is less efficient than that of normal neutrophils. We present evidence in support of MPO as a major arm of oxidative killing by neutrophils and propose that the essential contribution of MPO to normal innate host defense is manifest only when exposure to pathogens overwhelms the capacity of other host defense mechanisms.

Neutrophil, Myeloperoxidase and Oxidative MechanismsNitric Oxide and Endothelin EffectsImmune Response and InflammationBiologyFront lineMicroorganismMyeloperoxidaseMicrobiologyFront (military)Line (geometry)Cell biologyBacteriaImmunology

MeSH terms

AnimalsHumansImmunity, InnateInfectionsPeroxidaseNeutrophilsPhagocytosis

Funding

  • Office of Research and Development
  • National Institutes of Health
  • Health Research Council of New Zealand
Citations
652
FWCI
13.52
field-weighted impact
References
242
Percentile
99%
vs. same field & year
Citations per year
Cited by
ROS production in phagocytes: why, when, and where?
Journal of Leukocyte Biology · 2013 · 452 citations
Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function
Archives of Biochemistry and Biophysics · 2018 · 900 citations
References
Peroxynitrite oxidation of sulfhydryls.
Journal of Biological Chemistry · 1991 · 2,480 citations
Myeloperoxidase: friend and foe
Journal of Leukocyte Biology · 2005 · 2,237 citations
Myeloperoxidase-Halide-Hydrogen Peroxide Antibacterial System
Journal of Bacteriology · 1968 · 819 citations
How human neutrophils kill and degrade microbes: an integrated view
Immunological Reviews · 2007 · 737 citations
Myeloperoxidase and Cardiovascular Disease
Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 781 citations
Of Mice and Not Men: Differences between Mouse and Human Immunology
The Journal of Immunology · 2004 · 3,699 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.